Managing morbidly adherent placenta with conservative measures
Beni-Suef University Hospital Simplified Conservative Approach for Managing Placenta Accreta Spectrum: RCT
This study is testing new ways to manage a serious pregnancy condition called placenta accreta without having to remove the uterus, so women can keep their fertility and avoid complications.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 172 (estimated) |
| Ages | 25 Years to 45 Years |
| Sex | Female |
| Sponsor | Beni-Suef University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06465836 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of modified uterine artery ligation and myometrial compression as conservative measures for managing morbidly adherent placenta, specifically placenta accreta. The approach aims to avoid hysterectomy, which is often the standard treatment, in order to preserve fertility and minimize complications associated with surgical removal of the placenta. The study follows guidelines from the International Federation of Gynecology and Obstetrics (FIGO) and focuses on techniques that prevent excessive bleeding while maintaining the integrity of the placenta.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women over 28 weeks gestation with confirmed placenta previa and stable clinical conditions.
Not a fit: Patients experiencing significant vaginal bleeding or those with underlying medical disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could allow patients to preserve their fertility while effectively managing the risks associated with placenta accreta.
How similar studies have performed: While conservative management approaches have been explored, this specific methodology is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational age more than 28 weeks as determined by LMP and ultrasound. * Placenta previa as confirmed by ultrasound. * Clinically stable with no or mild vaginal bleeding. * No evidence of fetal compromise. * Patient consent. Exclusion Criteria: * Vaginal bleeding * Medical disorders
Where this trial is running
Cairo
- Beni-Suef University — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Hamada Ali, A. professor
- Email: hamadaashry@yahoo.com
- Phone: 0201007240754
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.